Israel Englander Senseonics Holdings, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 272,697 shares of SENS stock, worth $87,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares

272,697

Previous 442,666 38.4%

Holding current value

$87,263

Previous $177,000 46.33%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.32 - $0.49 $54,390 - $83,284	-169,969 Reduced 38.4%	272,697 $95,000
Q2 2024 Aug 14, 2024	SELL	$0.37 - $0.52 $59,386 - $83,462	-160,504 Reduced 26.61%	442,666 $177,000
Q1 2024 May 15, 2024	SELL	$0.5 - $0.73 $153,403 - $223,969	-306,807 Reduced 33.72%	603,170 $319,000
Q4 2023 Feb 14, 2024	SELL	$0.48 - $0.7 $2.68 Million - $3.91 Million	-5,578,973 Reduced 85.98%	909,977 $518,000
Q2 2023 Aug 14, 2023	BUY	$0.55 - $0.89 $3.51 Million - $5.68 Million	6,383,157 Added 6033.63%	6,488,950 $4.93 Million
Q1 2023 May 15, 2023	SELL	$0.68 - $1.25 $12,089 - $22,223	-17,779 Reduced 14.39%	105,793 $75,000
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.34 $302,201 - $421,822	-314,793 Reduced 71.81%	123,572 $127,000
Q3 2022 Nov 14, 2022	BUY	$1.02 - $2.23 $168,085 - $367,481	164,790 Added 60.24%	438,365 $579,000
Q2 2022 Aug 15, 2022	BUY	$0.94 - $1.94 $146,241 - $301,817	155,576 Added 131.85%	273,575 $282,000
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $64,934 - $156,432	42,165 Added 55.6%	117,999 $232,000
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $824,898 - $1.25 Million	-319,728 Reduced 80.83%	75,834 $202,000
Q3 2021 Nov 15, 2021	BUY	$2.77 - $4.05 $130,447 - $190,726	47,093 Added 13.51%	395,562 $1.34 Million
Q2 2021 Aug 16, 2021	SELL	$1.71 - $4.14 $171,610 - $415,477	-100,357 Reduced 22.36%	348,469 $1.34 Million
Q1 2021 May 17, 2021	BUY	$0.85 - $5.27 $18,488 - $114,627	21,751 Added 5.09%	448,826 $1.19 Million
Q4 2020 Feb 16, 2021	SELL	$0.36 - $0.95 $337,140 - $889,675	-936,500 Reduced 68.68%	427,075 $372,000
Q3 2020 Nov 16, 2020	SELL	$0.36 - $0.53 $49,528 - $72,917	-137,580 Reduced 9.16%	1,363,575 $528,000
Q2 2020 Aug 14, 2020	BUY	$0.39 - $0.69 $376,539 - $666,184	965,485 Added 180.24%	1,501,155 $585,000
Q1 2020 May 14, 2020	SELL	$0.56 - $1.62 $359,293 - $1.04 Million	-641,596 Reduced 54.5%	535,670 $339,000
Q4 2019 Feb 14, 2020	BUY	$0.83 - $1.3 $22,429 - $35,129	27,023 Added 2.35%	1,177,266 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$0.97 - $1.94 $3,830 - $7,661	3,949 Added 0.34%	1,150,243 $1.14 Million
Q2 2019 Aug 15, 2019	BUY	$1.81 - $2.45 $1.95 Million - $2.64 Million	1,078,465 Added 1589.98%	1,146,294 $2.34 Million
Q2 2019 Aug 14, 2019	BUY	$1.81 - $2.45 $39,119 - $52,951	21,613 Added 46.77%	67,829 $3.15 Million
Q1 2019 May 14, 2019	SELL	$2.3 - $3.27 $42,777 - $60,818	-18,599 Reduced 28.7%	46,216 $113,000
Q4 2018 Feb 14, 2019	SELL	$2.49 - $4.54 $3.24 Million - $5.91 Million	-1,301,591 Reduced 95.26%	64,815 $168,000
Q3 2018 Nov 14, 2018	BUY	$3.4 - $4.84 $1.21 Million - $1.73 Million	356,418 Added 35.29%	1,366,406 $6.52 Million
Q2 2018 Aug 14, 2018	SELL	$3.03 - $4.98 $1.14 Million - $1.88 Million	-377,578 Reduced 27.21%	1,009,988 $4.15 Million
Q1 2018 May 15, 2018	BUY	$2.48 - $3.21 $1.04 Million - $1.35 Million	420,358 Added 43.46%	1,387,566 $4.16 Million
Q4 2017 Feb 14, 2018	BUY	$2.43 - $3.54 $312,638 - $455,449	128,658 Added 15.34%	967,208 $2.57 Million
Q3 2017 Nov 14, 2017	BUY	$2.22 - $3.2 $1.86 Million - $2.68 Million	838,550	838,550 $2.68 Million

Others Institutions Holding SENS

# of Institutions

142

Shares Held

59.9M

Call Options Held

393K

Put Options Held

254K

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $149M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account